TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Pharma Nord Norge AS
Closing information (x1000 EUR)
| Closing information | 2022/12 | 2021/12 | 2020/12 |
| Turnover |
3,350
|
3,926
|
3,267 |
| Financial expenses |
2
|
3
|
3 |
| Earnings before taxes |
98
|
118
|
102 |
| Total assets |
1,735
|
2,055
|
1,663 |
| Current assets |
1,565
|
1,865
|
1,472 |
| Current liabilities |
1,616
|
1,909
|
1,487 |
| Equity capital |
106
|
132
|
161 |
| - share capital |
95
|
100
|
95 |
Financial ratios
| Fiscal year | 2022/12 | 2021/12 | 2020/12 |
| Solvency |
6.1%
|
6.4%
|
9.7% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
2.9%
|
3.0%
|
3.1% |
| Return on assets (ROA) |
5.8%
|
5.9%
|
6.3% |
| Current ratio |
96.8%
|
97.7%
|
99.0% |
| Return on equity (ROE) |
92.5%
|
89.4%
|
63.4% |
| Change turnover |
-370
|
481
|
829 |
| Change turnover % |
-10%
|
14%
|
34% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2022/12 | 2021/12 | 2020/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.